Shockwave balloon for severe mitral valve calcium
Part of Heart & circulation, Infections clinical trials.
This trial tests a special balloon (Shockwave) to treat severe calcium buildup in the mitral valve. It may help people with tight valve opening who cannot have standard surgery.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are older than 18 years
- You have severe mitral valve narrowing (valve area less than 1.5 cm²)
- You have dense calcium in the valve ring or leaflets (from aging or rheumatic heart disease)
- You do not have more than moderate leakage of the mitral valve
- You do not have a blood clot in the heart (checked by ultrasound)
- You are not pregnant and have no active bloodstream infection
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at a new type of balloon that uses sound waves to break up calcium in heart arteries before placing a stent, which may improve blood flow and reduce complications.
This trial tests a new single-use balloon catheter that uses sound waves to break up hardened calcium in heart arteries before placing a stent. It may help people with severe calcified blockages or completely blocked arteries that are hard to treat.
This trial tests a special balloon that uses shock waves to crack calcium in heart arteries, making it easier to place a stent. It is for people with chest pain or signs of heart strain due to a single, severely blocked artery with dense calcium.
This trial tests a new balloon catheter that uses sound waves to break up hard calcium blockages in heart arteries. It may be an option for people with stable chest pain or who have recovered from a recent heart attack, and who have a single, tough blockage.
This trial tests a new device that uses sound waves to soften calcium buildup in heart arteries before placing a stent. It may help people with hardened arteries get the stent placed more safely and effectively.
This trial tests a device called Shockwave M5+/L6 intravascular lithotripsy to help deliver stent grafts when the iliac (pelvic) arteries are extremely calcified and hard to access. It may help people who are being evaluated for endovascular (through-the-blood-vessel) treatment but whose anatomy makes standard access difficult.
Hear when a new Rheumatic Heart Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.